Cargando…
Translational molecular imaging in exocrine pancreatic cancer
Effective treatment for pancreatic cancer remains challenging, particularly the treatment of pancreatic ductal adenocarcinoma (PDAC), which makes up more than 95% of all pancreatic cancers. Late diagnosis and failure of chemotherapy and radiotherapy are all too common, and many patients die soon aft...
Autores principales: | Cornelissen, Bart, Knight, James C., Mukherjee, Somnath, Evangelista, Laura, Xavier, Catarina, Caobelli, Federico, Del Vecchio, Silvana, Rbah-Vidal, Latifa, Barbet, Jacques, de Jong, Marion, van Leeuwen, Fijs W. B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6208802/ https://www.ncbi.nlm.nih.gov/pubmed/30225616 http://dx.doi.org/10.1007/s00259-018-4146-5 |
Ejemplares similares
-
Generation of fluorescently labeled tracers – which features influence the translational potential?
por: van Leeuwen, Fijs W. B., et al.
Publicado: (2017) -
Cell Tracking in Cancer Immunotherapy
por: Perrin, Justine, et al.
Publicado: (2020) -
Pancreatic Exocrine Insufficiency in Pancreatic Cancer
por: Vujasinovic, Miroslav, et al.
Publicado: (2017) -
Exocrine Pancreatic Carcinogenesis and Autotaxin Expression
por: Kadekar, Sandeep, et al.
Publicado: (2012) -
Challenges in the management of pancreatic exocrine insufficiency
por: Shandro, Benjamin Myles, et al.
Publicado: (2018)